PROX1 and neoplasm: We evaluated the staining of PROX1 in the cytoplasm, whereas in the previous studies of CRC, hepatocellular carcinoma (HCC), and gliomas, only the staining in tumor cell nuclei were evaluated [24, 28, 33].